News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elekta AB (SE:EKTAB) and Key Distributor Enter Agreement to Increase Production Efforts of Radiotherapy Technology in Russia


10/29/2012 6:38:44 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta, (STO:EKTAB) a world leader in the design and manufacture of cancer treatment technology and software, and MSM-MEDIMPEX, a major Russian medical technology distributor, have announced their intention to set up production of radiotherapy equipment in Russia, with the intent to improve access to radiation therapy treatments to Russian citizens afflicted with cancer. Russia is the world’s ninth most populous country.

Read at BioSpace.com

comments powered by Disqus
Elekta AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES